ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I/IIa Safety & Immunogenicity of AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01865487
Recruitment Status : Completed
First Posted : May 31, 2013
Last Update Posted : January 5, 2016
Sponsor:
Collaborator:
Statens Serum Institut
Information provided by (Responsible Party):
Aeras

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2015
  Actual Study Completion Date : November 2015